chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered 7 booster doses from a vial initially stored in the refrigerator on 16Nov2021/  (beyond the 30 use by date)/ Moderna Covid-19 vaccine on 16Dec2021 from a vial which was initially sored in the refrigerator on 16Nov2021 at 10:00am; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 7 booster doses from a vial initially stored in the refrigerator on 16Nov2021/  (beyond the 30 use by date)/ Moderna Covid-19 vaccine on 16Dec2021 from a vial which was initially sored in the refrigerator on 16Nov2021 at 10:00am) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 7 booster doses from a vial initially stored in the refrigerator on 16Nov2021/  (beyond the 30 use by date)/ Moderna Covid-19 vaccine on 16Dec2021 from a vial which was initially sored in the refrigerator on 16Nov2021 at 10:00am). On 16-Dec-2021, EXPIRED PRODUCT ADMINISTERED (administered 7 booster doses from a vial initially stored in the refrigerator on 16Nov2021/  (beyond the 30 use by date)/ Moderna Covid-19 vaccine on 16Dec2021 from a vial which was initially sored in the refrigerator on 16Nov2021 at 10:00am) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  The vial was initially stored in the refrigerator on 16-Nov-2021. On 16-Dec-2021, the vial was first punctured. Per Tier 2 and the updated storage document, the vaccine was given before the end of day on day 30, therefore not an AE.   Most recent FOLLOW-UP information incorporated above includes: On 23-Dec-2021: Follow up document received on 23-Dec-2021 and significant follow AE updated (The vaccine was given before the end of day on day 30, therefore not an AE).
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, Antibody test, Blood immunoglobulin A, Extra dose administered, Myalgia
Clinical narrative: administration error and another booster shot was given; received booster dose instead of full dose; body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), EXTRA DOSE ADMINISTERED (administration error and another booster shot was given) and ACCIDENTAL UNDERDOSE (received booster dose instead of full dose) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced MYALGIA (body aches). On 17-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (received booster dose instead of full dose). On 18-Dec-2021, the patient experienced EXTRA DOSE ADMINISTERED (administration error and another booster shot was given). On 17-Dec-2021, ACCIDENTAL UNDERDOSE (received booster dose instead of full dose) had resolved. On 18-Dec-2021, EXTRA DOSE ADMINISTERED (administration error and another booster shot was given) had resolved. At the time of the report, MYALGIA (body aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: decreased (Low) low antibody primary immunodeficiency. On an unknown date, Blood immunoglobulin A: decreased (Low) low IGA level.         No concomitant medications reported by reporter No treatment medications provided by the reporter.  Patient was immunocompromised received booster dose instead of full dose on Friday 17-Dec-2021. Pharmacist made administration error and another booster shot was given on Saturday 18-Dec-2021 to equivalent full dose. Pharmacist claim he contacted Moderna to double check before giving second booster shot.   This case was linked to MOD-2021-417037 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Fatigue, Headache, Illness
Clinical narrative: stomach pain/ severe stomach pain; Sick; headache; feeling tired; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach pain/ severe stomach pain), ILLNESS (Sick), DIARRHOEA (diarrhea), HEADACHE (headache) and FATIGUE (feeling tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced DIARRHOEA (diarrhea). On 16-Dec-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain/ severe stomach pain), ILLNESS (Sick), HEADACHE (headache) and FATIGUE (feeling tired). At the time of the report, ABDOMINAL PAIN UPPER (stomach pain/ severe stomach pain), ILLNESS (Sick), HEADACHE (headache) and FATIGUE (feeling tired) had not resolved and DIARRHOEA (diarrhea) outcome was unknown.            Patient had her 1st and 2nd doses of the Moderna COVID-19 vaccine in Apr2021 and was not sure if that was the 1st or 2nd dose.   No relevant concomitant medications was reported. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Dec-2021: Follow-up received includes Event added diarrhea.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Chromaturia, Headache, Illness, Myalgia
Clinical narrative: urine's color is like an iced tea; chills; chilling with fever; terrible headache; got sick; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHROMATURIA (urine's color is like an iced tea), ILLNESS (got sick), MYALGIA (body aches), CHILLS (chills) and PYREXIA (chilling with fever) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE (First dose and Lot number CC) on 17-Mar-2021. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE.    On 19-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Dec-2021, the patient experienced ILLNESS (got sick), MYALGIA (body aches), PYREXIA (chilling with fever) and HEADACHE (terrible headache). On 21-Dec-2021, the patient experienced CHROMATURIA (urine's color is like an iced tea) and CHILLS (chills). At the time of the report, CHROMATURIA (urine's color is like an iced tea), MYALGIA (body aches) and CHILLS (chills) had not resolved and ILLNESS (got sick), PYREXIA (chilling with fever) and HEADACHE (terrible headache) outcome was unknown.            No concomitant medication was reported by the reporter. No treatment was reported by the reporter.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: urine's color is like an iced tea; chills; chilling with fever; terrible headache; got sick; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHROMATURIA (urine's color is like an iced tea), ILLNESS (got sick), MYALGIA (body aches), CHILLS (chills) and PYREXIA (chilling with fever) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE (First dose and Lot number CC) on 17-Mar-2021. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE.    On 19-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Dec-2021, the patient experienced ILLNESS (got sick), MYALGIA (body aches), PYREXIA (chilling with fever) and HEADACHE (terrible headache). On 21-Dec-2021, the patient experienced CHROMATURIA (urine's color is like an iced tea) and CHILLS (chills). At the time of the report, CHROMATURIA (urine's color is like an iced tea), MYALGIA (body aches) and CHILLS (chills) had not resolved and ILLNESS (got sick), PYREXIA (chilling with fever) and HEADACHE (terrible headache) outcome was unknown.            No concomitant medication was reported by the reporter. No treatment was reported by the reporter.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product storage error
Clinical narrative: 5 patients who got the Moderna booster after the vial was already punctured 20 times; Inappropriate schedule of Vaccine administered; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT STORAGE ERROR (5 patients who got the Moderna booster after the vial was already punctured 20 times) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of Vaccine administered) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939930) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (second Dose) on 03-May-2021. Past adverse reactions to the above products included No adverse event with Pfizer.    On 21-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Dec-2021, the patient experienced PRODUCT STORAGE ERROR (5 patients who got the Moderna booster after the vial was already punctured 20 times) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of Vaccine administered). On 21-Dec-2021, PRODUCT STORAGE ERROR (5 patients who got the Moderna booster after the vial was already punctured 20 times) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of Vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Treatment information was not reported.  The vial was removed from the refrigerator storage at 10 am and first puncture then, and the last dose was administered at 4 pm.. Dose were administered on upper deltoid.   This case was linked to MOD-2021-423252 (Patient Link).
Age: 56.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 55 patients received a dose of a vial after 12 hours of initial puncture; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture). On 11-Jun-2021, EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patients were given shots during excursions; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients were given shots during excursions) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 ml. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients were given shots during excursions). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (patients were given shots during excursions) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient's first and second doses were given elsewhere (Unknown product)  Concomitant medication information was not reported  Treatment information was not reported
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: Patients were given shots during excursions.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients were given shots during excursions.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients were given shots during excursions.). On 11-Nov-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients were given shots during excursions.) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information provided by the reporter. No treatment information provided by the reporter.   This case was linked to MOD-2021-423303 (Patient Link).
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site pain that  got worse through the days and got resolve.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site pain that  got worse through the days and got resolve.) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014f21a) for COVID-19 vaccination.     The patient's past medical history included Pericarditis (hospitalized due to pericarditis from 24-DEC-2018 to 25-DEC-2018) in December 2018. Concomitant products included LIOTHYRONINE, ANAKINRA and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 02-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Oct-2021, the patient experienced VACCINATION SITE PAIN (injection site pain that  got worse through the days and got resolve.). At the time of the report, VACCINATION SITE PAIN (injection site pain that  got worse through the days and got resolve.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to MOD-2021-423677 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Received booster half dose (0.25ml) for first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Received booster half dose (0.25ml) for first dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Dec-2021 at 5:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 21-Dec-2021 at 5:45 PM, the patient experienced ACCIDENTAL UNDERDOSE (Received booster half dose (0.25ml) for first dose). On 21-Dec-2021 at 5:45 PM, ACCIDENTAL UNDERDOSE (Received booster half dose (0.25ml) for first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient received first dose of Moderna COVID-19 vaccine as 0.25ml instead of 0.5ml. No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Hives; Rash; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) and RASH (Rash) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 031L20A) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives) and RASH (Rash). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives) and RASH (Rash) had not resolved.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Has a little muscular pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Has a little muscular pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Dec-2021 at 6:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced MYALGIA (Has a little muscular pain). At the time of the report, MYALGIA (Has a little muscular pain) outcome was unknown.            It was stated that Patient was trying to see if he can take Tylenol. No concomitant medications were mentioned. No treatment details were reported.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm pain; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (arm pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced PAIN IN EXTREMITY (arm pain). At the time of the report, PAIN IN EXTREMITY (arm pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-425166.
Sex: M
Vaccine: COVID19
Symptoms: Herpes virus infection
Clinical narrative: Herpes flare up; This spontaneous case was reported by a consumer and describes the occurrence of HERPES VIRUS INFECTION (Herpes flare up) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Herpes NOS.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES VIRUS INFECTION (Herpes flare up). At the time of the report, HERPES VIRUS INFECTION (Herpes flare up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported.  Patient reported that he is under Antiviral treatment for a herpes flare up.  Patient wanted to know if he should reschedule his second dose vaccination appointed for tomorrow 7-APR-2021 to a few days later.
Sex: U
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Patient only received maybe a quarter dose of vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient only received maybe a quarter dose of vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient only received maybe a quarter dose of vaccine). At the time of the report, ACCIDENTAL UNDERDOSE (Patient only received maybe a quarter dose of vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter No treatment information was provided by the reporter
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Headache, Malaise
Clinical narrative: started feeling bad about 30 hours after injection, gotten worse; after the Moderna booster shot, she's feeling ill; Pain across the shoulder, up to back of her head. Pretty bad headache; Pain across the shoulder, up to back of her head / Pain in the shoulder started 16 hours after the injection; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (started feeling bad about 30 hours after injection, gotten worse), MALAISE (after the Moderna booster shot, she's feeling ill), HEADACHE (Pain across the shoulder, up to back of her head. Pretty bad headache) and ARTHRALGIA (Pain across the shoulder, up to back of her head / Pain in the shoulder started 16 hours after the injection) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J21H) for COVID-19 vaccination.     The patient's past medical history included Stent placement (Last year had heart stent installed) in 2020. Concurrent medical conditions included Heart disease, unspecified (she was on some other heart medication) and Blood pressure abnormal. Concomitant products included GLYCERYL TRINITRATE (NITROGLYCERIN) for Chest pain, CLOPIDOGREL BISULFATE (PLAVIX), ATORVASTATIN CALCIUM (LIPITOR), LISINOPRIL, METOPROLOL SUCCINATE, ACETYLSALICYLIC ACID (ASPIRIN 81) and ATORVASTATIN for an unknown indication.   In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced FEELING ABNORMAL (started feeling bad about 30 hours after injection, gotten worse), MALAISE (after the Moderna booster shot, she's feeling ill), HEADACHE (Pain across the shoulder, up to back of her head. Pretty bad headache) and ARTHRALGIA (Pain across the shoulder, up to back of her head / Pain in the shoulder started 16 hours after the injection). At the time of the report, FEELING ABNORMAL (started feeling bad about 30 hours after injection, gotten worse), MALAISE (after the Moderna booster shot, she's feeling ill), HEADACHE (Pain across the shoulder, up to back of her head. Pretty bad headache) and ARTHRALGIA (Pain across the shoulder, up to back of her head / Pain in the shoulder started 16 hours after the injection) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter reported that the patient was on heart medication blood thinner and blood pressures pills. Not taken any treatment.   This case was linked to MOD-2021-423760, MOD-2021-423679, MOD-2021-423761 (Patient Link).
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 55 patients received a dose of a vial after 12 hours of initial puncture; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture). On 03-Nov-2021, EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment and concomitant mediations were not reported. Dose given at time of puncture 9/3/21, was obtained 6/1/21 and kept in freezer until date of puncture, then stored in refrigerator.
Age: 46.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 55 patients received a dose of a vial after 12 hours of initial puncture; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) in a 46-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment drug were reported.   This case was linked to MOD-2021-418964 (Patient Link).
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 vaccination.     Concurrent medical conditions included Dementia.    On 13-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose) had resolved.            No concomitant medication details was reported. No treatment medication details was reported.  The patient had been cancelling second dose appointments right before going in. It has already been 2 months since first dose, so reporter was wondering if patient needs to start the vaccine series all over again.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dysphagia, Oropharyngeal pain, Vaccination site pain
Clinical narrative: sore throat on right side; hard to swallow; diarrhea; soreness in my injection arm; real bad chills; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat on right side), DYSPHAGIA (hard to swallow), DIARRHOEA (diarrhea), VACCINATION SITE PAIN (soreness in my injection arm) and CHILLS (real bad chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 26-Nov-2020. Previously administered products included for COVID-19 vaccination: Pfizer COVID-19 vaccine in February 2021 and Pfizer COVID-19 vaccine in March 2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine and Pfizer COVID-19 vaccine.    On 20-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Dec-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat on right side), DYSPHAGIA (hard to swallow), DIARRHOEA (diarrhea), VACCINATION SITE PAIN (soreness in my injection arm) and CHILLS (real bad chills). The patient was treated with EUCALYPTUS GLOBULUS OIL, MENTHOL (HALLS) for Adverse event, at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (sore throat on right side), DYSPHAGIA (hard to swallow), DIARRHOEA (diarrhea), VACCINATION SITE PAIN (soreness in my injection arm) and CHILLS (real bad chills) outcome was unknown.            Concomitant medication of the patient was not reported.   Due to the real bad chills, the patient had to put on a jacket, socks and gloves along with 5 blankets on her. The patient took Halls cough drop, which helped some.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Hypoaesthesia, Neck pain, Oxygen saturation
Clinical narrative: half the sensation of pressure; neck is sore; fingertips are numb / thumbs are the best, ring finger are the worse/ feels like they fell asleep; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (half the sensation of pressure), NECK PAIN (neck is sore) and HYPOAESTHESIA (fingertips are numb / thumbs are the best, ring finger are the worse/ feels like they fell asleep) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included PREGABALIN (LYRICA), HYDROMORPHONE HYDROCHLORIDE (DILAUDID), TIZANIDINE and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 22-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Dec-2021, the patient experienced DISCOMFORT (half the sensation of pressure), NECK PAIN (neck is sore) and HYPOAESTHESIA (fingertips are numb / thumbs are the best, ring finger are the worse/ feels like they fell asleep). At the time of the report, DISCOMFORT (half the sensation of pressure), NECK PAIN (neck is sore) and HYPOAESTHESIA (fingertips are numb / thumbs are the best, ring finger are the worse/ feels like they fell asleep) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: perfect state (normal) Perfect state.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported being on pain medication protocols already and so he had not changed any medications. Patient stated that he could not tell the texture.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Feeding disorder, Headache, Myalgia, Nausea
Clinical narrative: real bad reaction; her stomach hurt real bad; She did not eat a thing.; real bad headache; it was all sour; nausea, did not throw up.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (real bad reaction), ABDOMINAL PAIN UPPER (her stomach hurt real bad), FEEDING DISORDER (She did not eat a thing.), HEADACHE (real bad headache) and MYALGIA (it was all sour) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Dec-2021, the patient experienced VACCINATION COMPLICATION (real bad reaction), ABDOMINAL PAIN UPPER (her stomach hurt real bad), FEEDING DISORDER (She did not eat a thing.), HEADACHE (real bad headache), MYALGIA (it was all sour) and NAUSEA (nausea, did not throw up.). At the time of the report, VACCINATION COMPLICATION (real bad reaction), ABDOMINAL PAIN UPPER (her stomach hurt real bad), FEEDING DISORDER (She did not eat a thing.), HEADACHE (real bad headache), MYALGIA (it was all sour) and NAUSEA (nausea, did not throw up.) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: real bad reaction; her stomach hurt real bad; She did not eat a thing.; real bad headache; it was all sour; nausea, did not throw up.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (real bad reaction), ABDOMINAL PAIN UPPER (her stomach hurt real bad), FEEDING DISORDER (She did not eat a thing.), HEADACHE (real bad headache) and MYALGIA (it was all sour) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Dec-2021, the patient experienced VACCINATION COMPLICATION (real bad reaction), ABDOMINAL PAIN UPPER (her stomach hurt real bad), FEEDING DISORDER (She did not eat a thing.), HEADACHE (real bad headache), MYALGIA (it was all sour) and NAUSEA (nausea, did not throw up.). At the time of the report, VACCINATION COMPLICATION (real bad reaction), ABDOMINAL PAIN UPPER (her stomach hurt real bad), FEEDING DISORDER (She did not eat a thing.), HEADACHE (real bad headache), MYALGIA (it was all sour) and NAUSEA (nausea, did not throw up.) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: giving Moderna vaccines subcutaneous instead of intramuscular; This spontaneous case was reported by a physician and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (giving Moderna vaccines subcutaneous instead of intramuscular) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (giving Moderna vaccines subcutaneous instead of intramuscular). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (giving Moderna vaccines subcutaneous instead of intramuscular) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine). On 21-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Administered with expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not provided.  The vial was initially stored in the refrigerator: it was taken directly from freezer, thawed and given to the patient on the same day 21-Dec-2021. The vial did not undergo any temperature excursions.  The patient had no adverse reaction so far, patient waited 15 min in the clinic, was observed fine and left.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: started to break out in hives/ hives still come and go/ on my face, arms, back, the bra area and on my feet; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (started to break out in hives/ hives still come and go/ on my face, arms, back, the bra area and on my feet) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) for an unknown indication.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021, the patient experienced URTICARIA (started to break out in hives/ hives still come and go/ on my face, arms, back, the bra area and on my feet). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (started to break out in hives/ hives still come and go/ on my face, arms, back, the bra area and on my feet) had not resolved.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Head discomfort, Headache, Rash, Vaccination complication
Clinical narrative: Rash on arm which turned to blisters; Could not pick head up off pillow; She had a reaction; A couple of days of vertigo; Rash on arm which turned to blisters; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Rash on arm which turned to blisters), HEAD DISCOMFORT (Could not pick head up off pillow), VACCINATION COMPLICATION (She had a reaction), VERTIGO (A couple of days of vertigo) and RASH (Rash on arm which turned to blisters) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis and Drug allergy (most pain medications). Concomitant products included RISEDRONATE SODIUM (ACTONEL), NITROFURANTOIN, FAMOTIDINE, ESTROGENS CONJUGATED (PREMARIN) and GABAPENTIN for an unknown indication.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLISTER (Rash on arm which turned to blisters), HEAD DISCOMFORT (Could not pick head up off pillow), VACCINATION COMPLICATION (She had a reaction), VERTIGO (A couple of days of vertigo), RASH (Rash on arm which turned to blisters) and HEADACHE (Headache). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) for Headache, at an unspecified dose and frequency. At the time of the report, BLISTER (Rash on arm which turned to blisters), HEAD DISCOMFORT (Could not pick head up off pillow), VACCINATION COMPLICATION (She had a reaction) and RASH (Rash on arm which turned to blisters) outcome was unknown, VERTIGO (A couple of days of vertigo) had resolved and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took aspirin through Excedrin when it got really bad. She also had multiple sclerosis and had took Actonel, nitrofurantoin, famotidine, Premarin and vitamins and calcium. Caller had this problem (vertigo) with other medications like gabapentin. Patient HCP told her not to get the second dose. Caller was allergic to most pain medications.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Rash on arm which turned to blisters; Could not pick head up off pillow; She had a reaction; A couple of days of vertigo; Rash on arm which turned to blisters; Headache; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Rash on arm which turned to blisters), HEAD DISCOMFORT (Could not pick head up off pillow), VACCINATION COMPLICATION (She had a reaction), VERTIGO (A couple of days of vertigo) and RASH (Rash on arm which turned to blisters) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis and Drug allergy (most pain medications). Concomitant products included RISEDRONATE SODIUM (ACTONEL), NITROFURANTOIN, FAMOTIDINE, ESTROGENS CONJUGATED (PREMARIN) and GABAPENTIN for an unknown indication.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLISTER (Rash on arm which turned to blisters), HEAD DISCOMFORT (Could not pick head up off pillow), VACCINATION COMPLICATION (She had a reaction), VERTIGO (A couple of days of vertigo), RASH (Rash on arm which turned to blisters) and HEADACHE (Headache). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) for Headache, at an unspecified dose and frequency. At the time of the report, BLISTER (Rash on arm which turned to blisters), HEAD DISCOMFORT (Could not pick head up off pillow), VACCINATION COMPLICATION (She had a reaction) and RASH (Rash on arm which turned to blisters) outcome was unknown, VERTIGO (A couple of days of vertigo) had resolved and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took aspirin through Excedrin when it got really bad. She also had multiple sclerosis and had took Actonel, nitrofurantoin, famotidine, Premarin and vitamins and calcium. Caller had this problem (vertigo) with other medications like gabapentin. Patient HCP told her not to get the second dose. Caller was allergic to most pain medications.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Booster dose administered >12 hours post puncture/what are the protocols if an expired dose was administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Booster dose administered >12 hours post puncture/what are the protocols if an expired dose was administered) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Booster dose administered >12 hours post puncture/what are the protocols if an expired dose was administered). On 23-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Booster dose administered >12 hours post puncture/what are the protocols if an expired dose was administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.  The dose was drawn out of a vial which was punctured more than 12 hours. No other AEs reported by HCP on behalf of patient.   Most recent FOLLOW-UP information incorporated above includes: On 23-Dec-2021: Non significant Follow-up received
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Nausea, Pyrexia, Vomiting
Clinical narrative: nauseas; high fever; excessive vomiting/throwing up 12 times; 10 weeks pregnant wife; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of NAUSEA (nauseas), PYREXIA (high fever), VOMITING (excessive vomiting/throwing up 12 times) and MATERNAL EXPOSURE DURING PREGNANCY (10 weeks pregnant wife) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032l20a and 011l20a) for COVID-19 vaccination.     Concurrent medical conditions included Pregnancy (Patient was pregnant with twins and it was reported that it was a high risk pregnancy.).   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 22-Dec-2021, the patient experienced NAUSEA (nauseas) and PYREXIA (high fever). 22-Dec-2021, the patient experienced VOMITING (excessive vomiting/throwing up 12 times) and MATERNAL EXPOSURE DURING PREGNANCY (10 weeks pregnant wife). The patient was treated with DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. On 22-Dec-2021, MATERNAL EXPOSURE DURING PREGNANCY (10 weeks pregnant wife) had resolved. At the time of the report, NAUSEA (nauseas), PYREXIA (high fever) and VOMITING (excessive vomiting/throwing up 12 times) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.  Patient was pregnant with twins and it was reported that it was a high-risk pregnancy.   Diclegis did not provide relief.  Estimated due date was reported as Jul-2022.